In Brief: House oversight hearing
This article was originally published in The Gray Sheet
Executive Summary
House oversight hearing: Rep. Joe Barton's (R-Tex.) House Commerce/Oversight Subcommittee will hold a hearing May 25 on drugs and biologics. Three panels are expected to testify, including: individuals who claim to have suffered as a result of FDA regulation; physicians who say they need certain pharmaceuticals but are unable to obtain them; and outside interest groups. The agency will not be asked to testify. A similar hearing focusing on FDA regulation of medical devices was held March 30 ("The Gray Sheet" April 3, p. 8). The subcommittee is said to be planning two additional hearings for this summer, with one focusing on think-tank proposals for FDA reform and the other on FDA's views...